M MENARINI MENARINI INTERNATIONAL - Trademark Details
Status: 700 - Registered
Serial Number
86794917
Registration Number
5748075
Word Mark
M MENARINI MENARINI INTERNATIONAL
Status
700 - Registered
Status Date
2019-05-14
Filing Date
2015-10-21
Registration Number
5748075
Registration Date
2019-05-14
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
010702, 260514, 260521 - Globes with meridians and parallel lines only. Three triangles. Triangles that are completely or partially shaded.
Published for Opposition Date
2016-04-05
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
LEHKER, DAWN FELDMAN
Statements
Indication of Colors claimed
The color(s) white, red, black and grey is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"INTERNATIONAL"
Description of Mark
The mark consists of an upper-case letter "M" outlined in grey, the interior of the letter is white, the two right triangles formed by the bottom of the "M" are the color red, and the large isosceles triangle formed at the top of the letter "M" is black and is bisected from bottom to top by the name "MENARINI" in upper case lettering in white. This is centered and superimposed over an elliptical globe in grey with longitude and latitude lines in white. Centered at the bottom beneath the letter "M" and the globe is the name "MENARINI INTERNATIONAL" in black in upper case lettering with the letters "M" and "I" slightly larger than the other letters in the name.
Goods and Services
Pharmaceutical products and preparations for the treatment of disorders of the alimentary tract and metabolism, stomatological preparations, antacids, drugs for functional gastrointestinal disorders, antiemetics, antinauseants, drugs for bile and liver therapy, laxatives, antidiarrheals, intestinal antiinflammatory/antiinfective agents, antiobesity preparations, digestives including enzymes, drugs used in diabetes, insulins and analogues, blood glucose lowering drugs, vitamins, mineral supplements, tonics, anabolic agents for systemic use, appetite stimulants, amino acids and derivatives, enzymes antithrombotics, antihemorrhagics, antianemics, blood substitutes and perfusion solutions, hematological agents, cardiovascular drugs, cardiac drugs, vasodilators, antihypertensives, diuretics, peripheral vasodilators, vasoprotectives, beta blocking agents, calcium channel blockers, agents acting on the renin-angiotensin system, lipid modifying agents, dermatoiogicals, antifungals for dermatological use, emollients, protectives, preparations for treatment of wounds and ulcers, antipruritics including antihistamines, anesthetics, antipsoriatics, antibiotics and chemotherapeutics for dermatological use, corticosteroids for dermatological use, antiseptics, disinfectants, medicated dressings, anti-acne preparations, medical shampoos, genito urinary system drugs, gynecological antiinfectives and antiseptics, oxytocics, contraceptives for topical use, sympathomimetics, labour repressants, prolactine inhibitors, antiinflammatory products for vaginal administration, sex hormones and modulators of the genital system, hormonal contraceptives for systemic use, urologicals including antispasmodics, benign prostatic hypertrophy drugs, systemic hormonal preparations, pituitary and hypothalamic hormones and analogues, corticosteroids for systemic use, thyroid preparations, pancreatic hormones, parathyroid hormones and analogues, anti-parathyroid agents, antiinfectives, antibacterials and antimycotics for systemic use, antivirals for systemic use, immune sera and immunoglobulins, vaccines, antineoplastic and immunomodulating agents, endocrine drugs, immunostimulants, immunosuppressants, musculo-skeletal system drugs, antiinflammatory and antirheumatic products, topical products for joint and muscular pain, muscle relaxants, antigout preparations, drugs for treatment of bone diseases, central nervous system drugs, anesthetics, analgesics, antipyretics, antimigraine preparations, antiepileptics, anti-parkinson drugs, psycholeptics, antipsychotics, anxiolytics, hypnotics, sedatives, psychoanaleptics, antidepressants, psychostimulants, anti-dementia drugs, parasympathomimetics, drugs used in addictive disorders, antivertigos, antiparasitics, insecticides, repellents, respiratory system drugs, nasal preparations, throat preparations, drugs for obstructive airway diseases, inhalants, cough and cold preparations, antihistamines for systemic use, lung surfactants, respiratory stimulants, ophthalmologicals, otologicals, allergens, antidotes, iron chelating agents, antihyperkalemics, antihyperphosphatemics, detoxyfying agents for antineoplastic treatment, antihypercalcemics, antihypoglycemics, drugs for embolisation, medical gases, nerve depressants, diagnostic agents, diet formulations for treatment of obesity, infant formulas, contrast media, diagnostic and therapeutic radiopharmaceuticals, surgical dressings
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-10-26
Primary Code
005
Current Trademark Owners
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
BHARATI BAKSHANI
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
Italy | False |
Trademark Events
Event Date | Event Description |
2015-10-24 | NEW APPLICATION ENTERED IN TRAM |
2015-10-26 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2015-10-27 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2015-11-20 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2015-12-08 | ASSIGNED TO LIE |
2015-12-09 | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED |
2016-02-11 | ASSIGNED TO EXAMINER |
2016-02-18 | DATA MODIFICATION COMPLETED |
2016-02-22 | EXAMINERS AMENDMENT -WRITTEN |
2016-02-22 | EXAMINERS AMENDMENT E-MAILED |
2016-02-22 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2016-02-22 | EXAMINER'S AMENDMENT ENTERED |
2016-02-22 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2016-02-29 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2016-03-16 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2016-04-05 | PUBLISHED FOR OPPOSITION |
2016-04-05 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2016-05-31 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2016-11-23 | TEAS EXTENSION RECEIVED |
2016-11-23 | EXTENSION 1 FILED |
2016-11-23 | EXTENSION 1 GRANTED |
2016-11-25 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2017-05-08 | TEAS EXTENSION RECEIVED |
2017-05-08 | EXTENSION 2 FILED |
2017-05-08 | EXTENSION 2 GRANTED |
2017-05-10 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2017-11-27 | TEAS EXTENSION RECEIVED |
2017-11-27 | EXTENSION 3 FILED |
2017-11-27 | EXTENSION 3 GRANTED |
2017-11-29 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2018-05-10 | TEAS EXTENSION RECEIVED |
2018-05-10 | EXTENSION 4 FILED |
2018-05-10 | EXTENSION 4 GRANTED |
2018-05-12 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2018-10-04 | TEAS EXTENSION RECEIVED |
2018-10-13 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2018-10-04 | EXTENSION 5 FILED |
2018-10-13 | EXTENSION 5 GRANTED |
2018-10-16 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-04-04 | TEAS DELETE 1(B) BASIS RECEIVED |
2019-04-04 | NOTICE OF ALLOWANCE CANCELLED |
2019-04-10 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
2019-05-14 | REGISTERED-PRINCIPAL REGISTER |